Eyal Epstein
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
- Virology top 10%
Papers in
-
- Bacillus and Francisella bacterial research 4
-
- SARS-CoV-2 and COVID-19 Research 9
- Viral Infections and Outbreaks Research 4
- Co-authors
- Ohad Mazor (15 shared papers)Ron Alcalay (13 shared papers)Tal Noy-Porat (10 shared papers)Nitya M. Jacob (1 shared paper)Wei‐Shou Hu (1 shared paper)Joon Chong Yee (1 shared paper)Michael J. Betenbaugh (1 shared paper)Anne Kantardjieff (1 shared paper)
- Journals
- Biologicals (2 papers)Toxins (2 papers)Antibodies (2 papers)Biotechnology and Bioengineering (2 papers)Current Opinion in Nephrology & Hypertension (2 papers)
- Partner nations
- IsraelUnited StatesSingapore
In The Last Decade
Eyal Epstein
37 papers receiving 592 citations
Peers
Comparison fields: 5 of 78
- Biotechnology 83
- Virology 39
- Immunology 131
- Infectious Diseases 90
- Molecular Biology 327
Countries citing papers authored by Eyal Epstein
This map shows the geographic impact of Eyal Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Epstein more than expected).
Fields of papers citing papers by Eyal Epstein
This network shows the impact of papers produced by Eyal Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Epstein. The network helps show where Eyal Epstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Eyal Epstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 122 | |
| 2 | 2004 | 45 | |
| 3 | 2016 | 35 | |
| 4 | 1989 | 31 | |
| 5 | 2000 | 29 | |
| 6 | 2021 | 27 | |
| 7 | 2021 | 21 | |
| 8 | 2012 | 21 | |
| 9 | 2015 | 19 | |
| 10 | 2017 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 1994 | 16 | |
| 14 | 1996 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2015 | 11 | |
| 19 | 2002 | 11 | |
| 20 | 2024 | 10 |
About Eyal Epstein
Eyal Epstein is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Genetics and Biotechnology, having authored 38 papers that have together received 606 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Toxin Mechanisms and Immunotoxins (6 papers), Transgenic Plants and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Viral Infections and Outbreaks Research (4 papers), Bacillus and Francisella bacterial research (4 papers), Parathyroid Disorders and Treatments (4 papers) and Poxvirus research and outbreaks (3 papers). The work is most often cited by research in Biotechnology (83 citations), Virology (39 citations), Immunology (131 citations), Infectious Diseases (90 citations) and Molecular Biology (327 citations). Eyal Epstein has collaborated with scholars based in Israel, United States and Singapore. Frequent co-authors include Ohad Mazor, Ron Alcalay, Tal Noy-Porat, Nitya M. Jacob, Wei‐Shou Hu, Joon Chong Yee, Michael J. Betenbaugh, Anne Kantardjieff, Yee Jiun Kok and Robin Philp. Their work appears in journals such as Biologicals, Toxins, Antibodies, Biotechnology and Bioengineering and Current Opinion in Nephrology & Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.